Nursing care
Prostate Cancer nursing care: what to assess and what to do first
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Prostate cancer nursing centres on assessing urinary and sexual function, supporting decision-making around PSA screening and treatment, and managing the consequences of surgery, radiation or hormone therapy. Most cases are slow-growing and detected via PSA or digital rectal exam. The nurse's core role is honest conversation, not persuasion toward testing.
What it is and why it happens
Prostate cancer is a malignancy of the prostate gland, almost always adenocarcinoma, arising in the peripheral zone where it often grows slowly for years before causing symptoms. Risk rises sharply with age, particularly after 50, and further with a first-degree relative history or Black ethnicity, both of which are associated with earlier onset and more aggressive disease. Androgens drive tumour growth, which is why androgen deprivation therapy is a mainstay once the disease is advanced or high-risk.
Because many prostate cancers are indolent, the biggest clinical tension is not diagnosis but decision-making. A tumour found on biopsy may never threaten life expectancy, yet treatment carries real harms: incontinence, erectile dysfunction, bowel injury from radiation. This is the context nurses work within. PSA screening is a shared decision rather than a rule, and the nursing role is the conversation, not the test itself. Guidelines from bodies such as the USPSTF recommend individualised discussion for men aged 55 to 69 rather than blanket screening.
How it presents — what you will actually see
Early prostate cancer is usually silent. When it does surface, symptoms overlap heavily with benign prostatic hyperplasia: weak urinary stream, hesitancy, nocturia, incomplete emptying. This overlap is exactly why a raised PSA or abnormal digital rectal exam finding needs biopsy confirmation rather than being read as diagnostic on its own.
Locally advanced disease can bring haematuria, new-onset erectile dysfunction, or perineal discomfort. Metastatic disease most often announces itself through bone pain, especially in the lower back, pelvis or hips, since prostate cancer has a strong tendency to spread to bone. Pathological fracture, spinal cord compression from vertebral metastases, and unexplained weight loss are red flags that point to advanced or metastatic disease and warrant urgent escalation rather than routine follow-up.
Nursing assessment priorities
Take a focused urinary history: stream strength, frequency, nocturia, straining, and any haematuria, alongside a baseline continence and erectile function assessment before treatment starts. This baseline matters because post-treatment changes are common and patients need something to compare against, not just a vague sense that things got worse.
Screen for bone pain and ask specifically about back pain in any man with known or suspected prostate cancer, since new spinal pain in this population is a possible cord compression until ruled out. Assess psychological response to diagnosis and to the screening conversation itself; men often carry unspoken anxiety about incontinence and sexual function that shapes whether they pursue or avoid treatment. Review current medications for anticholinergics or alpha-blockers that affect urinary symptoms, and confirm understanding of what PSA results do and do not mean before any procedure.
Interventions and what to do first
If a patient presents with acute urinary retention, first priority is bladder decompression via catheterisation, followed by monitoring for post-obstructive diuresis. If new back pain with leg weakness, numbness, or bowel or bladder dysfunction is reported, treat this as suspected cord compression: escalate immediately for imaging, since delay can mean permanent paralysis.
For men undergoing radical prostatectomy, prioritise catheter care, pelvic floor exercise teaching, and early mobilisation to reduce venous thromboembolism risk. For those starting androgen deprivation therapy, prepare them for hot flushes, loss of libido, and bone density loss, and coordinate baseline bone density scanning where indicated. Throughout, support the shared decision-making process around PSA and treatment choice by providing balanced information rather than steering the patient toward any single path; document that this conversation happened and what the patient decided.
Complications to watch for
Watch for urinary incontinence and erectile dysfunction after surgery or radiation, both of which can be distressing enough to affect adherence to follow-up care. Radiation cystitis and proctitis can cause haematuria, urgency, or rectal bleeding weeks to months after treatment, and patients should know these are possible late effects rather than signs of new disease.
In metastatic disease, monitor for spinal cord compression, pathological fracture, and hypercalcaemia of malignancy, presenting with confusion, constipation, and polyuria. Androgen deprivation therapy carries long-term risks of osteoporosis, cardiovascular disease, and metabolic syndrome, so baseline and ongoing monitoring of bone density, lipids, and glucose should be built into follow-up rather than treated as an afterthought.
Patient teaching before discharge
Teach catheter care and pelvic floor exercises to any patient discharged post-prostatectomy, with realistic timelines: continence often improves over months, not days, and setting that expectation reduces distress. Explain what to watch for with the catheter, including signs of infection or blockage, and confirm a clear follow-up date for removal.
Cover the practical side of erectile dysfunction management, including that treatment options exist and referral is appropriate if it persists. For men on androgen deprivation therapy, teach strategies for hot flush management and the importance of weight-bearing exercise for bone health. Reinforce that PSA will be monitored post-treatment to check for recurrence, and that a single fluctuating value is not automatically a crisis. Ensure the patient leaves with a written follow-up plan and knows who to contact with questions.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our renal and genitourinary practice questions are the closest set to what this page covers.
Common questions
Should nurses recommend PSA screening to patients?
No. Nurses should present balanced information about benefits and harms and support the patient's own decision rather than recommending for or against testing. Major guidelines frame PSA screening between ages 55 and 69 as an individualised choice, not a default. Document that the discussion took place and what the patient decided.
Is a raised PSA the same as a prostate cancer diagnosis?
No. PSA can rise with benign prostatic hyperplasia, prostatitis, or recent instrumentation, not only cancer. A raised PSA prompts further evaluation, typically biopsy, rather than confirming malignancy on its own.
What is the first sign of prostate cancer spreading to bone?
New or worsening bone pain, especially in the lower back, pelvis, or hips, is the classic early sign of skeletal metastasis. Any new back pain with neurological symptoms in a man with prostate cancer needs urgent evaluation for spinal cord compression.
How long does incontinence last after radical prostatectomy?
Many men see significant improvement over three to twelve months with consistent pelvic floor exercises, though a smaller proportion have longer-term stress incontinence. Set this timeline expectation before discharge so patients don't interpret early leakage as permanent failure.
What are the priority nursing actions for suspected spinal cord compression?
Escalate immediately for urgent imaging and specialist review, keep the patient still to avoid further cord injury, and monitor closely for progression of weakness, numbness, or loss of bowel and bladder control. This is a time-critical emergency, not a routine referral.